Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Latest Posted June 26, 2024
FDA Warns Consumers Not to Use Infla-650 Due to Undeclared Drugs
On June 20, 2024, the FDA warned consumers not to purchase or use Infla-650 after FDA laboratory analysis found them to contain acetaminophen, diclofenac, and phenylbutazone.
Acetaminophen is an over-the-counter (OTC) pain reliever that can cause a rare, but potentially fatal skin reaction, and, in large doses, liver damage. Diclofenac is a prescription non-steroidal anti-inflammatory drug (NSAID) that can cause serious cardiovascular events such as heart attack or stroke, as well as bleeding, ulceration, and fatal tears of the stomach and intestines, or liver toxicity.
Phenylbutazone is a non-steroidal anti-inflammatory drug (NSAID) that was discontinued for human use in the United States due to the risk of serious and life-threatening injuries, including bone marrow toxicity. People with anemia, a low white or red blood cell count, or decreased blood platelets may be at a greater risk of death or serious injury.
Infla-650 capsules (see product photos) are promoted as an herbal dietary supplement for pain and sold on various websites, including nutraherbusa.com, and potentially in some retail stores. The product’s herbal ingredients listed include ashwagandha, fenugreek seed, shilajit, and more.
Consumers and healthcare providers can report any adverse reactions to the FDA’s MedWatch Voluntary Reporting Program.
For more information, use the link below.
Infla-650 contains hidden drug ingredients
See related recalls and warnings:
FDA Warns Consumers Not to Use Tapee Tea
Toxic Herb Found In Weight Supplements
FDA Warns Consumers of Supplement Containing Prescription Anti-Inflammatory Drug
FDA Warns Consumers Not to Use Ossos-Sans Supplement for Joints
Drug Found in Umary Supplement
Acetaminophen is an over-the-counter (OTC) pain reliever that can cause a rare, but potentially fatal skin reaction, and, in large doses, liver damage. Diclofenac is a prescription non-steroidal anti-inflammatory drug (NSAID) that can cause serious cardiovascular events such as heart attack or stroke, as well as bleeding, ulceration, and fatal tears of the stomach and intestines, or liver toxicity.
Phenylbutazone is a non-steroidal anti-inflammatory drug (NSAID) that was discontinued for human use in the United States due to the risk of serious and life-threatening injuries, including bone marrow toxicity. People with anemia, a low white or red blood cell count, or decreased blood platelets may be at a greater risk of death or serious injury.
Infla-650 capsules (see product photos) are promoted as an herbal dietary supplement for pain and sold on various websites, including nutraherbusa.com, and potentially in some retail stores. The product’s herbal ingredients listed include ashwagandha, fenugreek seed, shilajit, and more.
Consumers and healthcare providers can report any adverse reactions to the FDA’s MedWatch Voluntary Reporting Program.
For more information, use the link below.
Infla-650 contains hidden drug ingredients
See related recalls and warnings:
FDA Warns Consumers Not to Use Tapee Tea
Toxic Herb Found In Weight Supplements
FDA Warns Consumers of Supplement Containing Prescription Anti-Inflammatory Drug
FDA Warns Consumers Not to Use Ossos-Sans Supplement for Joints
Drug Found in Umary Supplement
Other Recent Recalls & Warnings
Recall Update for Certain Metabolife Bars - Excessive Vitamin A
January 31, 2002
Recall of Certain Iron Supplements
January 19, 2002
Recall of Pepsin-containing Digestive Supplements
January 18, 2002
Recall of "Prostatin" Supplement -- Contains Aristolochic Acid
January 15, 2002
Canada Requests Recall of Certain Ephedra/Ephedrine Products
January 11, 2002
Liver Toxicity with Kava
January 07, 2002
For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please visit the FDA MedWatch website.